OpenEvidence has raised $210 million in new funding on a $3.5 billion valuation to expand its AI-powered medical search and decision tools.
The company offers an AI-powered search and decision-support platform for clinicians to access medical knowledge in real time, based on peer-reviewed medical literature.
OpenEvidence has strategic content partnerships with major medical publishers, such as the American Medical Association and The New England Journal of Medicine.
The company's platform, used in over 10,000 U.S. hospitals, includes a clinician-facing AI search interface and the recently released AI agent, OpenEvidence DeepConsult, to help physicians with medical research.